CircEAF2 counteracts Epstein-Barr virus-positive diffuse large B-cell lymphoma progression via miR-BART19-3p/APC/β-catenin axis

par Chen-xing Zhao, Zi-xun Yan, Jing-jing Wen, Di Fu, Peng-peng Xu, Li Wang, Shu Cheng, Jian-da Hu, Wei-li Zhao
Publié 2021

JAM-A overexpression is related to disease progression in diffuse large B-cell lymphoma and downregulated by lenalidomide

par Peng-Peng Xu, Yi-Feng Sun, Ying Fang, Qi Song, Zi-Xun Yan, Yi Chen, Xu-Feng Jiang, Xiao-Chun Fei, Yan Zhao, Christophe Leboeuf, Biao Li, Chao-Fu Wang, Anne Janin, Li Wang, Wei-Li Zhao
Publié 2017

Clinical and molecular features of Epstein‐Barr virus‐positive diffuse large B‐cell lymphoma: Results in a multi‐center trial

par Chen Xing Zhao, Jing Jing Wen, Di Fu, Peng Peng Xu, Shu Cheng, Li Wang, Chao Fu Wang, Xiao Chun Fei, Xin Wang, Jian Feng Zhou, Li Ping Su, Zhuo Wen Chen, Jie Ping Chen, Mei Yun Fang, Ting Liu, Yong Ping Song, Kang Yu, Yan Li, Jian Gu, Ming Hou, Wei Li Zhao, Jian da Hu
Publié 2021